UNSPSC 51281655: Micronomicin sulfate

This classification denotes an aminoglycoside antibiotic with the molecular formula 2C20H41N5O7.5H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 09H5UKQ7TZ, chemically known as d-streptamine, o-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-.alpha.-d-erythro-hexopyranosyl-(1-4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1-6))-2-deoxy-, sulfate (salt), but more generally known as micronomicin sulfate, which bears US NIH Compound Identifier 171808.

European Medicines Agency schedules micronomicin sulfate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08945MIG. Most nations, for tariff purposes, schedule micronomicin sulfate under HS 29419000. SMILES:.

UNSPSC 51281655 Micronomicin sulfate is a Commodity code that in practice captures a much broader scope of pharmaceutical procurement by state and local governments than its specific drug name suggests. Recent state and local solicitations tagged to this code actually cover naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products supplied through authorized wholesalers, and medical and first aid supplies for emergency response operations. The issuing bodies span county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa Fire Department Rescue Division), and cooperative purchasing alliances serving multiple states (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving Minnesota, Oregon, and member jurisdictions). This breadth reflects how state and local procurement offices tag pharmaceutical and medical consumable purchases to narrower UNSPSC codes even when the actual acquisition spans product families.

Recent activity concentrates in Florida, Texas, Minnesota, and Oregon, with Seminole County's IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 safe drug deactivation systems annually, due July 26, 2023) and the City of Tampa's invitation to bid for 169 line items of medical and first aid supplies for its Fire Department Rescue Division (estimated $700,000, due March 13, 2026, sheltered as a Small Local Business Enterprise opportunity with a 5 percent bid discount capped at $10,000) representing recent municipal activity. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026) requiring NDC-specific submissions through three authorized wholesalers with cGMP and Drug Supply Chain Security Act compliance; the contract term is two years with optional extensions. The Texas Health and Human Services Commission issued an RFI (due April 3, 2026) to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking vendor experience with direct contracting for self-insured employers and value-based agreements outside traditional pharmacy benefit manager relationships. State and local activity under this code skews toward established-vendor relationships through cooperative purchasing and authorized-wholesaler channels rather than single-source manufacturer awards.